Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)
Phase 3
Completed
- Conditions
- Non Cystic Fibrosis Bronchiectasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Aradigm Corporation
- Target Recruit Count
- 304
- Registration Number
- NCT02104245
Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)
Phase 3
Completed
- Conditions
- Non Cystic Fibrosis Bronchiectasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Aradigm Corporation
- Target Recruit Count
- 278
- Registration Number
- NCT01515007
Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa
- First Posted Date
- 2010-03-23
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Aradigm Corporation
- Registration Number
- NCT01090908
Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"
Phase 2
Completed
- Conditions
- Non-Cystic Fibrosis Bronchiectasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- Aradigm Corporation
- Target Recruit Count
- 95
- Registration Number
- NCT00889967
- Locations
- 🇬🇧
"1st Floor, Nuffield House, B15 2TH, Birmingham, Britain, United Kingdom
🇬🇧"Ground Floor, Tower Block, Lisburn Road, Belfast, Britain, United Kingdom
🇬🇧"Stott Lane, Salford, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath